Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.07M | 8.31M | 8.74M | 8.96M | 8.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.81M | 20.72M | 21.46M | 22.32M | 20.61M |
| Operating Income | -14.81M | -20.72M | -21.46M | -22.32M | -20.61M |
| Income Before Tax | -13.11M | -15.70M | -15.33M | -26.92M | -11.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.11M | -15.70M | -15.33M | -26.92M | -11.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.11M | -15.70M | -15.33M | -26.92M | -11.18M |
| EBIT | -14.81M | -20.72M | -21.46M | -22.32M | -20.61M |
| EBITDA | -14.29M | -20.27M | -21.02M | -21.87M | -20.21M |
| EPS Basic | -0.07 | -0.10 | -0.12 | -0.21 | -0.09 |
| Normalized Basic EPS | -0.04 | -0.06 | -0.08 | -0.13 | -0.06 |
| EPS Diluted | -0.07 | -0.10 | -0.12 | -0.21 | -0.09 |
| Normalized Diluted EPS | -0.04 | -0.06 | -0.08 | -0.13 | -0.06 |
| Average Basic Shares Outstanding | 175.12M | 155.14M | 126.99M | 126.13M | 123.52M |
| Average Diluted Shares Outstanding | 175.12M | 155.14M | 126.99M | 126.13M | 123.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |